Caspofungin for the treatment of pediatric fungal infections.
Fisher
Brian T
BT
Divisions of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Zaoutis
Theoklis
T
D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy*; D001230:Aspergillus / Q000187:drug effects; D002175:Candida / Q000187:drug effects; D002177:Candidiasis / Q000188:drug therapy*; D000077336:Caspofungin; D002648:Child; D002675:Child, Preschool; D017277:Drug Approval; D054714:Echinocandins / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D055666:Lipopeptides; D014481:United States; D014486:United States Food and Drug Administration
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D000077336:Caspofungin